Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GAL-021 repeated stepped infusion study with alfentanil in healthy volunteers
NL-OMON23830Recruiting
- Sponsor
- Galleon Pharmaceuticals
- Start
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of ENA-001 in respiratory failure and opioid-induced respiratory depression (OIRD) (2 arms), sponsored by Galleon Pharmaceuticals. Primary endpoints: Safety and tolerability, Respiratory parameters and 3 more. Started Nov 2012; status: recruiting.
02
Drugs
ENA-001
03
Conditions
respiratory failureopioid-induced respiratory depression (OIRD)
Beyond the preview
Go deeper on NL-OMON23830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON23830.